Cost-effectiveness of Telemedicine-directed Specialized vs Standard Care for Patients With Inflammatory Bowel Diseases in a Randomized Trial
Marin J. de Jong, Annelies Boonen, Andrea E. van der Meulen‐de Jong, Mariëlle Romberg‐Camps, Ad A. van Bodegraven, Nofel Mahmmod, Tineke Markus, Gerard Dijkstra, Björn Winkens, Astrid van Tubergen, Ad Masclee, Daisy Jonkers, Marie J. Pierik
Topics & Concepts
MedicineTelemedicineRandomized controlled trialInflammatory Bowel DiseasesInflammatory bowel diseaseMEDLINEStandard of careIntensive care medicineInternal medicineHealth carePolitical scienceLawEconomicsDiseaseEconomic growthInflammatory Bowel DiseaseTelemedicine and Telehealth ImplementationRheumatoid Arthritis Research and Therapies